Clinical trialNCT05653388RecruitingObservational

Metastatic Leiomyosarcoma Biomarker Protocol

SponsorUniversity of Michigan Rogel Cancer CenterEnrollment200Leiomyosarcoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Scott Schuetze
University of Michigan Rogel Cancer Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
Recruiting
Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
Recruiting

United States

Sarcoma Oncology Research Center
Santa Monica, California, United States
Sant P Chawla, MD
Recruiting
University of Miami
Miami, Florida, United States
Gina D'Amato, MD
Recruiting
Dana- Farber
Boston, Massachusetts, United States
Recruiting
University of Michigan Cancer Center
Ann Arbor, Michigan, United States
Scott Schuetze, M.D., PhD
Recruiting
Mayo Clinic
Rochester, Minnesota, United States
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting
Ohio State University
Columbus, Ohio, United States
Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Recruiting
Md Anderson
Houston, Texas, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 22 Dec 2022
Primary completion: 31 Dec 2026
Completion: 31 Dec 2026
Last update posted: 24 Jun 2026
Registered enrollment: 200
Registry id: NCT05653388

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.